Biocardia Inc (BCDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,244 | -4,761 | -2,712 | -7,946 | -5,650 |
| Depreciation Amortization | 21 | 17 | 12 | 67 | 52 |
| Accounts receivable | N/A | -10 | N/A | 97 | 87 |
| Other Working Capital | 640 | 1,013 | 815 | -1,217 | -654 |
| Other Operating Activity | 644 | 474 | 267 | 973 | 712 |
| Operating Cash Flow | $-4,939 | $-3,267 | $-1,618 | $-8,026 | $-5,453 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -1 | N/A | -6 | -5 |
| Investing Cash Flow | $-1 | $-1 | $N/A | $-6 | $-5 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,690 | 1,907 | 212 | 10,552 | 10,513 |
| Other Financing Activity | -834 | -30 | -16 | -1,252 | -1,228 |
| Financing Cash Flow | $7,856 | $1,877 | $196 | $9,300 | $9,285 |
| Beginning Cash Position | 2,371 | 2,371 | 2,371 | 1,103 | 1,103 |
| End Cash Position | 5,287 | 980 | 949 | 2,371 | 4,930 |
| Net Cash Flow | $2,916 | $-1,391 | $-1,422 | $1,268 | $3,827 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,939 | -3,267 | -1,618 | -8,026 | -5,453 |
| Capital Expenditure | -1 | -1 | N/A | -6 | -5 |
| Free Cash Flow | -4,940 | -3,268 | -1,618 | -8,032 | -5,458 |